Berna Bozkurt Duman

Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study

Meral Günaldı, Berna Bozkurt Duman, Çiğdem Usul Afşar et al. · Journal of Oncology Pharmacy Practice · 2015 · 52 citations

Medicine, Oncology, Pharmacology +17

Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment

Şermin Börekçi, Ersan Atahan, Deniz Demir Yılmaz et al. · Respiration · 2015 · 41 citations · Full text

Medicine, Immunology, Infectious Diseases +10

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

Kadir Eser, Arif Hakan Önder, Emel Sezer et al. · BMC Cancer · 2022 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma

Vehbi Erçolak, Semra Paydaş, Melek Ergin et al. · Acta Haematologica · 2015 · 24 citations

Medicine, Oncology, Pathology +17

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Seda Kahraman, Enes Erul, Mustafa Seyyar et al. · Future Oncology · 2023 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17